These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1271406)

  • 1. Metabolic formation and synthesis of 1-(3-chlorophenyl)-2(4-hydroxyphenyl)-1-methyl-2(2 pyridine)ethanol. A potential hypocholesteremic agent.
    Sinsheimer JE; Van den Eeckhout E; Hewitt LE; Kido Y; Wade DR; Hansen DW; Drach JC; Burckhalter JH
    J Med Chem; 1976 May; 19(5):647-50. PubMed ID: 1271406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dehydrative metabolites of 1-(3-chlorophenyl)-1methyl-2-phenyl-2-(2-pyridine)ethanol as potential hypocholesteremic agents.
    Kokosa JM; Sinsheimer JE; Wade DR; Drach JC; Burckhalter JH
    J Med Chem; 1978 Feb; 21(2):225-8. PubMed ID: 621720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-(2-Pyridine)benzyl aryl ketones as potential hypocholesteremic agents.
    Hewitt LE; Wade DR; Sinsheimer JE; Wang JH; Drach JC; Burckhalter JH
    J Med Chem; 1978 Dec; 21(12):1339-40. PubMed ID: 722749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocholesteremic agents. I. Substituted stilbazoles and dihydrostilbazoles.
    Villani FJ; Ellis CA; Tavares RF; Steinberg M; Tolksdorf S
    J Med Chem; 1970 May; 13(3):359-66. PubMed ID: 5459028
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of hepatic lipid biosynthesis by 1-(3-chlorophenyl)-1-methyl-2-phenyl-2-(2-pyridine) ethanol, a hypocholesterolemic agent.
    Ishidate K; Drach JC; Sinsheimer JE; Burckhalter JH
    Biochem Pharmacol; 1980 Dec; 29(23):3207-10. PubMed ID: 7447958
    [No Abstract]   [Full Text] [Related]  

  • 6. Potential hypocholesteremic derivatives of styrylacetic acid II: cis- and trans-3-methyl-4-phenyl-3-butenoic acid analogs.
    Stratford ES; Smith LM; Tomecko GW
    J Pharm Sci; 1978 Jan; 67(1):80-3. PubMed ID: 563441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New hypocholesteremic tertiary alcohols].
    Boissier JR; Ratouis R; Dumont C; Lesbros J; Lavaux JP
    Arzneimittelforschung; 1967 Sep; 17(9):1193-6. PubMed ID: 5632297
    [No Abstract]   [Full Text] [Related]  

  • 8. Discovery of Novel 3-Piperidinyl Pyridine Derivatives as Highly Potent and Selective Cholesterol 24-Hydroxylase (CH24H) Inhibitors.
    Kajita Y; Ikeda S; Yoshikawa M; Fukuda H; Watanabe E; Yano J; Lane W; Miyamoto M; Ishii T; Nishi T; Koike T
    J Med Chem; 2022 Feb; 65(4):3343-3358. PubMed ID: 35166541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-aralkyl-piperidyl carbanilates as hypocholesteremic agents.
    O'Brien DE; Rost WJ
    J Pharm Sci; 1970 Mar; 59(3):303-5. PubMed ID: 5416166
    [No Abstract]   [Full Text] [Related]  

  • 10. [Studies on hypolipidemic agents. III. Syntheses and hypocholesteremic activities of morpholino and trifluoromethyl derivatives (author's transl)].
    Miyoshi F; Nagao K
    Yakugaku Zasshi; 1974 Aug; 94(8):1028-32. PubMed ID: 4472623
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypocholesteremic derivatives of styrylacetic acid. 1. gem-Dimethyl analogs of benzalbutyric acid.
    Statford ES
    J Med Chem; 1975 Mar; 18(3):242-5. PubMed ID: 1133812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14alpha-demethylase (CYP51).
    Korosec T; Acimovic J; Seliskar M; Kocjan D; Tacer KF; Rozman D; Urleb U
    Bioorg Med Chem; 2008 Jan; 16(1):209-21. PubMed ID: 17964172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of 2-phenol-4-chlorophenyl-6-aryl pyridines as topoisomerase II inhibitors and cytotoxic agents.
    Thapa P; Kadayat TM; Park S; Shin S; Thapa Magar TB; Bist G; Shrestha A; Na Y; Kwon Y; Lee ES
    Bioorg Chem; 2016 Jun; 66():145-59. PubMed ID: 27174797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Aralkyl-N-methylaminoethyl carbanilates as hypocholesteremic agents.
    Rost WJ; Sutton BM; Blank B; Pfeiffer FR; Holmes WL; Ditullio NW; Ingram EB
    J Pharm Sci; 1967 Dec; 56(12):1598-603. PubMed ID: 5588711
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypocholesteremic agents. IV. Some substituted piperazines.
    Wright HB; Martin DL
    J Med Chem; 1968 Mar; 11(2):390-1. PubMed ID: 5663639
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of molecular modification on hypocholesteremic activity of 1,3-bis(substituted phenoxy)-2-propanones and related derivatives.
    Wyrick SD; Piantadosi C
    J Med Chem; 1978 Apr; 21(4):386-90. PubMed ID: 650666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HYPOCHOLESTEREMIC AGENTS. I. PYRIDYL CARBINOLS.
    WRIGHT HB; DUNNIGAN DA; BIERMACHER U
    J Med Chem; 1964 Jan; 7():113-5. PubMed ID: 14186010
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis and biological activity of new HMG-CoA reductase inhibitors. 1. Lactones of pyridine- and pyrimidine-substituted 3,5-dihydroxy-6-heptenoic (-heptanoic) acids.
    Beck G; Kesseler K; Baader E; Bartmann W; Bergmann A; Granzer E; Jendralla H; von Kerekjarto B; Krause R; Paulus E
    J Med Chem; 1990 Jan; 33(1):52-60. PubMed ID: 2296036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsteroidal hypocholesteremic agents. II. The synthesis and serum sterol lowering properties of 4-(2'-dialkylaminoalkoxy)-4'-substituted biphenyls and related compounds.
    Bach FL; Barclay JC; Kende F; Cohen E
    J Med Chem; 1968 Sep; 11(5):987-93. PubMed ID: 5697112
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonsteroidal hypocholesteremic agents. I. The synthesis and serum sterol lowering properties of substituted 4-(2-dialkylaminoethoxy)diphenylamines and related compounds.
    Bach FL; Barclay JC; Cohen E
    J Med Chem; 1967 Sep; 10(5):802-6. PubMed ID: 6048485
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.